StemTech Russia is OPEN !

It’s official.

Russia Stemtech is open for business

Russia Stemtech is open for business

Stemtech have moved from “soft launch” to “LAUNCH”, which means StemTech Russia is now open 2 December 2013.

If you’ve been waiting to join the stem cell business, or simply waiting for the products to become available, then now it’s YOUR turn to join the world leader in stem cell nutrition and reap the benefits.


Instructions To Purchase StemTech Products in Russia


There are 2 StemTech products in RussiaSE2 (Цена: 2 535,00 р) and Dermastem (Цена: 4 875,00 р).

These are available for direct purchase over the internet.


Instructions To Become A StemTech Distributor in Russia


All Market Pending StemTech Distributors in Russia have until December 31st 2013* to become official Stemtech Independent Business Partners by purchasing either a Basic , TeamBuilder or Manager TeamBuilder Kit.

Those who do not join officially on or before December 31st 2013 will automatically be converted to VIP customers only and will not have any chance to earn commissions until such time as they do purchase any one of the joining offers and become an official Independent Business Partner

If you have previously joined during the “soft launch” period, then simply follow these directions:

1. Log in to your back office at, just as you would normally do, with your same user name and password
2. You will be prompted to choose your preferred joining Kit
3. Complete the process, and you will be enabled to convert to an Independent Business Partner
4. SUPPORT: Call us on +359 7001 0180. All the Partner Setrvies team speak English and will be only too happy to help!   customer services (9 am- 6 pm Moscow Time)
5. NOTE: The products offered in Russia at this stage will be SE2 and Dermastem only


A pre-launch meeting is scheduled for March 29, 2014 in Russia.




StemTech to Open in Russia from 15 November 2013 | StemTech Russia

Stemtech Russia is here !StemTech Russia Launch

Comrades  – GOOD NEWS !

News just in from Stemtech International is that they have  set November 15th as Stemtech’s soft launch in Russia.

This will guarantee that our Russian partners will enjoy both SE2 and Dermastem in their starter packs while ensuring that all systems are fully operational to begin this exciting new market.

The Grand Opening of StemTech Russia will mark our 30th country in November 2013.

SE2 and Dermastem have been readily available in other countries for some time now, and now the positive benefits of these stem cell release products will enable people to enrich their health and their skin with easy access to via website online ordering.


Stem Cells a Step Closer to Being Used as Therapy

Article originally from News Australia.

opIN a major breakthrough scientists have reprogrammed stem cells inside living mice so they can become any cell type in the mouse body.

It is the first time this feat has been achieved outside a test tube and could eventually lead to the use of stem cells in curing damaged organs or studying cancer.

The discovery by Spanish researchers reported in the journal Nature today showed multiple cells in a living mouse could be changed back into induced pluripotent stem cells (IPS).

These are a type of cell that can turn into muscle, bone, skin or other cells.

To prove the concept the researchers fed special mice high doses of an antibiotic that produced embryonic-like tumours in the mice called teratomas.

These tumours appeared in a variety of organs in the mouse indicating different cell types could be reset to an embryonic state.

CSIRO stem cell expert Associate Professor Andrew Laslett told the Australian Science Media Centre turning multiple different cells back into IPS cells was “unprecedented”.

This research will enable further investigations into applications targeted at treating specific diseases and injuries.

“The reprogramming method described is not suitable for use in humans, but its use for research in mice could ultimately provide information critical for the safe use of reprogramming technology in humans to address unmet healthcare needs,” he said.

The scientists in the study were unable to control which cells they reprogrammed and this type of control would be essential before stem cells could be used in medical treatment, Professor Laslett told News Corporation.

The research might also provide a new way of studying cancer development, he said.

The head of the Cancer Cell Biology Program at Melbourne’s Peter MacCallum Cancer Centre Professor Rob Ramsay said the findings are “a genuine leap forward in understanding the possibilities of reprogramming cells in many different organs in animals.”

It brought “the promise of therapies that fundamentally alter the make-up of cells a little closer to clinical use,” he told the Australian Science Media Centre.

British scientist Prof Robin Lovell-Badge said the research showed we need to be careful how we handle the reprogramming factors.

“Otherwise people exposed to them are very likely to develop teratomas, which are not going to be very good for the person,” he said.

Professor Laslett said his own research, published last month showed the way you make pluripotent stem cells can influence whether tumours form or don’t form

Stem cells: Living adult tissue transformed back into embryo state

News article originally posted on BBC News.


The living tissue inside an animal has been regressed back into an embryonic state for the first time, Spanish researchers say.

They believe it could lead to new ways of repairing the body, for example after a heart attack.

However, the study published in the journal Nature, showed the technique led to tumours forming in mice.

Stem cell experts said it was a “cool” study, but would need to be much more controlled before leading to therapies.

When an egg is first fertilised, it has the potential to develop into every tissue in the human body, from brain cells to skin.

That flexibility is lost as an embryo develops. However, transforming adult tissues back into an embryonic-like state may lead to treatments that can regenerate a weakened heart, or the light-sensing cells in the eye or even the brain after a stroke.

‘Thought impossible’

The transformation has been done in a laboratory, by treating skin samples with a mix of chemicals or genetic modification.

Now scientists at the Spanish National Cancer Research Centre in Madrid have achieved the same results inside an animal.

“It is a surprising result, this was not expected, most of us thought that it would be impossible,” lead researcher Prof Manuel Serrano told the BBC.

The research group used mice genetically modified to switch on, when they were given a specific drug, production of four chemicals shown to reverse a tissue’s destiny in the laboratory.

Tissues were successfully transformed back into an embryonic state, but without further direction they rapidly developed into tumours.

Speaking on Science In Action on the BBC World Service, Prof Serrano said: “Of course this is not what we want for regenerative medicine.

“We want to turn back the clock in a controlled manner and this is something we have to work out in the future.

“We have to find conditions where we reprogramme only partially so that they acquire a plastic state and repair the tissue.”

‘Monumental task’

Prof Robin Ali, from the Institute of Ophthalmology in London, is using stem cell technology to rebuild the retina to restore sight. He said the “ultimate goal” would be some treatment that could regenerate the back of the eye, “but that is a long way off”.

He added: “This is a really elegant study with important implications for the field.

“It will be a monumental task to prove this is safe, as what you’re doing is innately dangerous, but it is exciting as it’s potentially a new strategy for regenerative medicine.”

The technique was able to turn the clock back further than any other stem cell technology, including stem cells taken from an embryo.

Previous techniques produce stem cells that make the tissues found in the body. This study could also make those needed to support an embryo in the womb, such as the placenta.

Prof Robin Lovell-Badge, from the MRC’s National Institute of Medical Research, told the BBC that he could not see this technique leading directly to therapies, but rather improving scientific understanding.

“To me the interesting thing was the evidence that the cells correspond to an earlier stage of development.

“If we can repeat that with human cells, it would be incredibly useful and could have important research implications, such as understanding the placenta and how to help maintain a pregnancy.”

Prof Chris Mason, a stem cell scientist at University College London, said: “Overall it’s very cool and potentially very exciting, but it has massive issues in terms of control.”

Instead he thought techniques that transformed cells in the body directly into the desired tissue would be better than going via stem cells.

“It’s like a tree, instead of going down from a branch to the root and back up to a different branch, maybe we’ll be able to jump from branch to branch.”

RSS News

  • CDC and Texas Health Department confirm first Ebola case diagnosed in the U.S. September 30, 2014
    The Centers for Disease Control and Prevention (CDC) confirmed today, through laboratory tests, the first case of Ebola to be diagnosed in the United States in a person who had traveled to Dallas, Texas from Liberia. The patient did not have symptoms when leaving West Africa, but developed symptoms approximately four days after arriving in […]
  • Improving babies' language skills before they're even old enough to speak September 30, 2014
    In the first months of life, when babies begin to distinguish sounds that make up language from all the other sounds in the world, they can be trained to more effectively recognize which sounds “might” be language, accelerating the development of the brain maps which are critical to language acquisition and processing, according to new […]
  • Study uncovers important process for immune system development September 30, 2014
    Immunologists reveals new information about how our immune system functions, shedding light on a vital process that determines how the body's ability to fight infection develops.